// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

Temporal Trends In Medical Complications After Acute Ischemic Strokes In The United States From 2006-2017

Rashid Ahmed - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Risk Stratification Models For Stroke In Patients Hospitalized With Covid-19 Infection An American Heart Association Covid-19 CVD Registry Study

Alexander E Merkler - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Quality Of Ischemic Stroke Care Before And After The Covid-19 Pandemic

Adriana B Conforto - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Postpartum Risk Of Cerebral Venous Thrombosis

Tehniyat Baig - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Direct Oral Anticoagulants Vs. Vitamin K Antagonists In Patients With Cerebral Venous Thrombosis A Systematic Review And Meta-analysis

Shadi Yaghi - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Comparison Of Direct Oral Anticoagulants To Vitamin K Antagonists For Treatment Of Cerebral Venous Sinus Thrombosis

Mariyam Humayun - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Cerebral Sinovenous Thrombosis In Preterm Infants

Mahendranath D Moharir - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Age Stratified Risk Of Cerebral Venous Sinus Thrombosis After Sars-Cov-2 Vaccination

Katarzyna Krzywicka - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Population Incidence Of Cerebral Venous Thrombosis (CVT) From A Large Canadian Cohort 2001-2017

Lily Zhou - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Venous Thromboembolism Readmission In Acute Ischemic Stroke

Liqi Shu - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Comparison Of Pharmacologic And Physical Venous Thromboembolism Prophylaxis A Single Center Descriptive Analysis

Sukhmani Sandhu - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Incidence Of Pediatric And Neonatal Cerebral Venous Sinus Thrombosis In The United States (US)

Lily Zhou - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Pediatric Acute Stroke Team Activation Differentiating Stroke From Mimics

William D Wood - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Pregnancy-related Factors Associated With Stroke In Mothers And Newborns Data From The International Maternal Newborn Stroke Registry

Asish K Gulati - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The Role Of Interleukin-1α Cytokine In Poststroke Inflammation

Eloise Lemarchand - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Interleukin

Real-world Outcomes After Carotid Artery Stenting

Maryam Syed - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Aspirin

Hematological And Embolic Biomarkers And Clinical Outcomes In Patients With Cancer And Ischemic Stroke

Babak B Navi - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Thrombomodulin alfa

Delayed Administration Of A Repurposed Drug With Sigma 1 Receptor Activity Improves Stroke Outcomes In Male Rats

Derek Schreihofer - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Promethazine Hydrochloride

Treatment Resistant Primary Membranous Nephropathy due to concomitant occurrence of Secondary Membranous Nephropathy from Merkle Cell Carcinoma.

Tariku T. Gudura - National Kidney Foundation (NKF) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

Lisinopril

Seronegative Full-house Immune Complex Glomerulonephritis Post-mRNA COVID-19 Vaccination

Kaitlin Hellie - National Kidney Foundation (NKF) , 2022

Therapeutic Area

Disease

Drug/Treatment

Urology

Venous thrombosis

Cyclophosphamide

Copyright © 2026. QuantiNova All rights reserved